{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:49:24Z","timestamp":1787240964238,"version":"build-2736575974"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T00:00:00Z","timestamp":1413763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110555","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T18:11:53Z","timestamp":1413828713000},"page":"e110555","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants"],"prefix":"10.1371","volume":"9","author":[{"given":"Eva","family":"Haastrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thorball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Vedel","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-0-585-37970-8_12","article-title":"Anhedonic and anxiogenic effects of cytokine exposure","volume":"461","author":"H Anisman","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-1591(02)00009-0","article-title":"Cytokines, stress, and depressive illness","volume":"16","author":"H Anisman","year":"2002","journal-title":"Brain Behav Immun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb09597.x","article-title":"Cytokines and sickness behavior","volume":"840","author":"R Dantzer","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity","volume":"500","author":"R Dantzer","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref5","first-page":"287","article-title":"The cytokine hypothesis of depression: inflammation, oxidative &amp; nitrosative stress (IO&amp;NS) and leaky gut as new targets for adjunctive treatments in depression","volume":"29","author":"M Maes","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","article-title":"Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression","volume":"34","author":"M Maes","year":"1995","journal-title":"Journal of Affective Disorders"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression","volume":"65","author":"AH Miller","year":"2009","journal-title":"Biological Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"CL Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"RS Smith","year":"1991","journal-title":"Med Hypotheses"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo major depression","volume":"197","author":"JA Pasco","year":"2010","journal-title":"Br J Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.psy.0000256574.30389.1b","article-title":"Associations between depressive symptoms and inflammatory\/hemostatic markers in women during the menopausal transition","volume":"69","author":"KA Matthews","year":"2007","journal-title":"Psychosom Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/PSY.0b013e3181ec4b98","article-title":"Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"72","author":"DJ Deverts","year":"2010","journal-title":"Psychosom Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals","volume":"70","author":"MK Wium-Andersen","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00365510701432509","article-title":"Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein","volume":"67","author":"HP Sennels","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","article-title":"Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications","volume":"43","author":"EM Macy","year":"1997","journal-title":"Clin Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/clinchem\/47.3.444","article-title":"Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults","volume":"47","author":"IS Ockene","year":"2001","journal-title":"Clin Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"O Andersen","year":"2008","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.2001.00719.x","article-title":"Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia","volume":"59","author":"S Florquin","year":"2001","journal-title":"Kidney Int"},{"key":"ref19","first-page":"717","article-title":"Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance","volume":"79","author":"CF Sier","year":"1999","journal-title":"Lab Invest"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Backes Y, van der Sluijs KF, Mackie DP, Tacke F, Koch A, <etal>et al<\/etal>.. (2012) Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med.","DOI":"10.1007\/s00134-012-2613-1"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"J Eugen-Olsen","year":"2010","journal-title":"J Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lyngbaek S, Sehestedt T, Marott JL, Hansen TW, Olsen MH, <etal>et al<\/etal>.. (2012) CRP and suPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol.","DOI":"10.1016\/j.ijcard.2012.03.040"},{"key":"ref23","unstructured":"The Danish State Serum Institute S (2014) Medical product Statistics. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ssi.dk\" xlink:type=\"simple\">www.ssi.dk<\/ext-link>."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1017\/S1041610206004376","article-title":"Treatment with antidepressants in patients with dementia\u2013a nationwide register-based study","volume":"19","author":"LV Kessing","year":"2007","journal-title":"Int Psychogeriatr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/YIC.0b013e3282f1c200","article-title":"Increased rate of treatment with antidepressants in patients with multiple sclerosis","volume":"23","author":"LV Kessing","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.PSY.0000041542.29808.01","article-title":"Association between depression and elevated C-reactive protein","volume":"65","author":"M Danner","year":"2003","journal-title":"Psychosom Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PSY.0b013e31819e333a","article-title":"Depression and C-reactive protein: population-based Health 2000 Study","volume":"71","author":"M Elovainio","year":"2009","journal-title":"Psychosom Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archinte.164.9.1010","article-title":"Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey","volume":"164","author":"DE Ford","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis","volume":"24","author":"RJ Anderson","year":"2001","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","article-title":"Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings","volume":"158","author":"DL Musselman","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0079-6123(08)62130-5","article-title":"Depression really does hurt your heart: stress, depression, and cardiovascular disease","volume":"122","author":"DL Musselman","year":"2000","journal-title":"Prog Brain Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-3223(03)00413-X","article-title":"Depression in cancer: new developments regarding diagnosis and treatment","volume":"54","author":"CL Raison","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e80686","DOI":"10.1371\/journal.pone.0080686","article-title":"Vitamin D status during pregnancy and the risk of subsequent postpartum depression: a case-control study","volume":"8","author":"NO Nielsen","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Manderbacka K, Sund R, Koski S, Keskimaki I, Elovainio M (2010) Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997\u20132007. Pharmacoepidemiol Drug Saf.","DOI":"10.1002\/pds.2072"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0447.2008.01282.x","article-title":"Misclassification and the use of register-based indicators for depression","volume":"119","author":"K Thielen","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Langkilde AA, Hansen TW, Ladelund S, Linneberg A, Andersen O, <etal>et al<\/etal>.. (2011) Increased plasma soluble uPAR level is a risk marker of respiratory cancer in initially cancer-free individuals. Cancer Epidemiol Biomarkers Prev.","DOI":"10.1158\/1055-9965.EPI-10-1009"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0889-1591(03)00057-6","article-title":"Pathways linking depression, adiposity, and inflammatory markers in healthy young adults","volume":"17","author":"GE Miller","year":"2003","journal-title":"Brain Behav Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/oby.2009.333","article-title":"The longitudinal association from obesity to depression: results from the 12-year National Population Health Survey","volume":"18","author":"G Gariepy","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1537-2995.2007.01425.x","article-title":"Improving health profile of blood donors as a consequence of transfusion safety efforts","volume":"47","author":"G Edgren","year":"2007","journal-title":"Transfusion"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/bmj.314.7083.793","article-title":"Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland","volume":"314","author":"TP Tuomainen","year":"1997","journal-title":"BMJ"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e51698","DOI":"10.1371\/journal.pone.0051698","article-title":"Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort study","volume":"7","author":"A Langkilde","year":"2012","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000095222","article-title":"Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities","volume":"13","author":"AB Andersen","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.qai.0000157950.02076.a6","article-title":"High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients","volume":"39","author":"SR Ostrowski","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.20076","article-title":"The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations","volume":"55","author":"P Cinque","year":"2004","journal-title":"Ann Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0304-3940(02)00168-4","article-title":"Cortical neurons of Creutzfeldt-Jakob disease patients express the urokinase-type plasminogen activator receptor","volume":"324","author":"MH Deininger","year":"2002","journal-title":"Neurosci Lett"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0165-5728(00)00368-4","article-title":"Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria","volume":"111","author":"S Fauser","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/brain\/124.10.1978","article-title":"Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage","volume":"124","author":"D Gveric","year":"2001","journal-title":"Brain"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(01)03298-X","article-title":"Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains","volume":"926","author":"DG Walker","year":"2002","journal-title":"Brain Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/glia.20892","article-title":"Microglia and the urokinase plasminogen activator receptor\/uPA system in innate brain inflammation","volume":"57","author":"O Cunningham","year":"2009","journal-title":"Glia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T20:04:18Z","timestamp":1598385858000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110555"}},"subtitle":[],"editor":[{"given":"Carmen","family":"Infante-Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110555","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]}}}